Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel
The Pharma Data
OCTOBER 27, 2020
“The MassARRAY SARS-CoV-2 Panel is the only assay on the market with 5 viral genome targets multiplexed into a single reaction, making it robust against potential mutations arising in the viral genome,” said Dr. Darryl Irwin , Vice President of Scientific Affairs. ” More information is available at www.agenabio.com.
52 
Let's personalize your content